NeurologyFebruary 1, 2019
Better Biomarkers Could Help Us Treat Alzheimer’s
We need better molecular biomarkers to create targeted drugs
Stories by Howard M. Fillit
Howard M. Fillit is founding executive director and chief science officer at the Alzheimer's Drug Discovery Foundation in New York City.
MedicineSeptember 21, 2018
We Need New Biomarkers for Alzheimer's Disease
They're essential to coming up with better treatments, and a new initiative could provide them